期刊文献+

我院850例中西药联合应用药物不良反应分析 被引量:5

Chinese and western medicine combined application analysis of adverse drug reactions
在线阅读 下载PDF
导出
摘要 目的:结合本院一段时间内中西药联合应用的不良反应发生情况,探究在中西药联合应用中药物不良反应的发生现状。方法:2015年7~12月期间,我院接受治疗的患者,以应用中西药物联合治疗的850例患者中90例出现不良反应的患者作为研究对象,通过问卷调查以及病例信息的综合评估,从而对中西药联合应用过程中存在的问题以及防范措施进行归纳分析。结果:在中西药联合应用过程中出现不良反应的形势较为严峻,850例患者中中西药物联合方式组成中分为西药与中药注射剂、中成药以及中药汤剂的联合应用治疗,其涉及泌尿系统、消化道系统、皮肤和黏膜系统和心血管系统,并且在药物应用过程中没有得到足够重视。结论:在中西医药物应用过程中需要做好咨询工作,并且结合不良反应病症的常见诱发因素进行针对性解决和护理。 Objective: The combined drug use caused adverse reactions of Chinese and western medicines were explored.Methods: During July 2015 to December 2015, combination therapy with Chinese and western drugs in our hospital were 850 cases, among which 90 cases of adverse reaction of patients as the research object were chosen. Through questionnaire survey and case information comprehensive evaluation, the existing problems and preventive measures were summarized.Results: In the process of combined application of Chinese and western medicine, adverse reaction is more serious. 850 patients were divided into joint way of western medicine and traditional Chinese medicine injections, proprietary Chinese medicine and Chinese medicine medicinal broth of combined use of treatment, and are related to urinary system, digestive system, skin and mucous membrane system and cardiovascular system, and have not been paid enough attention in the process of drug application.Conclusion: Combination therapy of traditional Chinese and western medicine needs careful consulting, and paid more attention considering the common factors caused by adverse drug reactions.
出处 《药品评价》 CAS 2016年第6期37-39,共3页 Drug Evaluation
关键词 中西药联合 药物 不良反应 Joint of Traditional Chinese Medicine Drugs Adverse Reactions
  • 相关文献

参考文献9

二级参考文献47

  • 1罗磊.国外中西药联用引起的不良反应综述[J].中医药学报,2004,32(5):57-58. 被引量:4
  • 2颜春鲁,程卫东,李立.灯盏花、穿琥宁注射液与抗休克血管活性药物及抗胆碱药物配伍可行性研究[J].甘肃中医,2006,19(2):36-38. 被引量:7
  • 3陈颖,车庆明,何红.左氧氟沙星对黄芩苷血药浓度的影响[J].中国新药杂志,2006,15(4):266-268. 被引量:4
  • 4张海英,张斌,李玉珍.华法林的相互作用及其安全应用[J].药物不良反应杂志,2007,9(2):112-116. 被引量:65
  • 5康义瑶.中药注射剂面临大考:使用不规范致安全事件频发[N].医药经济报,2008-11-07(2).
  • 6Golomb BA, Evans MA. Statin adverse effects: A review of the literature and evidence for a mitochondrial mechanism [J]. Am J Cardiovasc Drugs, 2008,8 (6) : 373-418.
  • 7Schech S,Graham D,Staffa J,et al. Risk factors for statin-associated rhabdomyolysis[J].Pharmacoepidemiol Drug Saf,2007,16 (3): 352-358.
  • 8Egger SS, Ratz Bravo AE, Hess L, et al. Age-related differences in the prevalence of potential drug-drug interactions in ambulatory dyslipidaemic patients treated with statins[J].Drugs Aging, 2007,24(5 ): 429-440.
  • 9Card JW, Racz WJ, Brien JF, et al. Attenuation of amiodarone- induced pulmonary fibrosis by vitamin e is associated with suppression of transforming growth factor-beta1 gene expression but not prevention of mitochondrial dysfunction [J]. J Pharmacol Exp Ther, 2003,304( 1 ) : 277-283,.
  • 10Chapplain JM, Beillot J, Begue JM, et al. Mitochondrial abnormalities in hiv-infected lipoatrophic patients treated with antiretroviral agents [ J ]. J Acquir Immune Defic Syndr, 2004,37 (4): 1477-1488.

共引文献69

同被引文献28

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部